Company news

Bausch Health Companies Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Bausch Health's Gastroenterology Business, Salix, to Present New Data on Cirrhosis Trends and Severe Alcohol-Associated Hepatitis at The Liver Meeting® 2026

November 6, 2026

Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027

October 28, 2026

Bausch Health Announces US$50 Million Share Repurchase Program

October 28, 2026

Bausch Health announces third quarter 2026 results, raises guidance

October 28, 2026

Bausch Health Canada Announces Expanded Public Reimbursement for (Pr)OKEDI® (Risperidone for Extended-Release Injectable Suspension) Across Canada for the Treatment of Schizophrenia

October 19, 2026

Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway

October 12, 2026

Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance

October 12, 2026

Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026

October 6, 2026

Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets

September 8, 2026

(Pr)SILIQ® (brodalumab injection) Now Reimbursed Under Alberta's Public Drug Plan, Improving Access for Eligible Patients with Moderate to Severe Plaque Psoriasis

September 8, 2026

Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia

September 1, 2026

Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners

August 27, 2026

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners

August 17, 2026

Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board

August 6, 2026

Bausch Health announces second quarter 2026 results, raises guidance

July 29, 2026

(Pr)ELIDEL® (pimecrolimus) cream Now Reimbursed Under Alberta's Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitis

July 28, 2026

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026

July 7, 2026

Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia

July 6, 2026

Michael Goettler Resigns from Bausch Health's Board of Directors

July 1, 2026

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia

June 9, 2026

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China

May 28, 2026

Bausch Health Announces 2026 Annual Meeting of Shareholder Results

May 19, 2026

Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference

May 13, 2026

Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference

May 12, 2026

Bausch Health announces first quarter 2026 results

April 29, 2026

Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering

April 14, 2026

Bausch Health to Announce First Quarter 2026 Results on April 29, 2026

March 31, 2026

Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program

March 26, 2026

Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada

February 23, 2026

Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres

February 19, 2026

Bausch Health announces fourth quarter and Full-Year 2025 results

February 18, 2026

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

February 17, 2026

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program

February 11, 2026

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

January 23, 2026

Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026

January 21, 2026

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 5, 2026

Bausch Health Announces Final Results and Expiration of Exchange Offers

December 23, 2025

Beauty Devices Markets, Competition and Regional Analysis (2025-2032) Featuring Alma Lasers, Bausch Health, BRAUN, Conair, Cutera, FOREO and More

December 23, 2025

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

December 8, 2025

Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China

December 1, 2025

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

November 24, 2025

Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference

November 18, 2025

Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

November 5, 2025

Europe Photodynamic Therapy Market Size, Trends, Leading Applications and Pricing Benchmarks (2025-2033) Featuring Gladerma, Sun Pharmaceutical, Biofrontera, Lumibird, Bausch Health Companies and More

October 31, 2025

Bausch Health Announces Third Quarter 2025 Results

October 29, 2025

Bausch Health Announces Results of Special Meeting of Shareholders

October 9, 2025

George Medicines strengthens global commercialization strategy for GMRx2 with exclusive Biolab Farmacêutica licensing agreement in Brazil

October 2, 2025

Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV

September 30, 2025

Bausch Health to Announce Third Quarter 2025 Results on October 29

September 30, 2025

Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

September 29, 2025

Older news releases →

Calls

The 5 newest of 32 calls. Every call is listed under its year.

Decks

The 5 newest of 81 decks. Every deck is listed under its year.